Observational studyBMC pediatrics2026
Association of concomitant congenital anomalies with long-term renal outcomes in children with posterior urethral valves.
Observational study in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPosterior urethral valves (PUV) are the most common cause of congenital bladder outlet obstruction in boys and may result in long-term impairment of both bladder and renal function. In addition to the obstructive process itself, concomitant congenital anomalies may further influence renal outcome. This study aimed to evaluate the spectrum of associated congenital anomalies in children with PUV and to examine their relationship with clinically significant chronic kidney disease (CKD) during follow-up.
methodsThis retrospective single-center observational study included 103 boys with cystoscopically confirmed PUV who were diagnosed and followed at the Pediatric Urology Clinic of Eskişehir Osmangazi University Faculty of Medicine between January 2014 and December 2024. Patients with incomplete records or follow-up shorter than 12 months were excluded. Demographic characteristics, antenatal findings, presenting symptoms, vesicoureteral reflux (VUR), associated anomalies, imaging findings, interventions, bladder assessment findings, and renal outcomes were reviewed. Descriptive statistical analysis was performed. Clinically significant CKD was defined as persistent estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73 m² for more than 3 months, corresponding to CKD stage ≥ 2.
resultsThe median age at diagnosis was 2.4 years. Antenatal hydronephrosis and/or hydroureteronephrosis was present in 42 patients (40.8%), and concomitant VUR was detected in 39 (37.9%). Associated anomalies included hypospadias in 7 patients (6.8%), ureteropelvic junction obstruction in 7 (6.8%), renal hypodysplasia in 5 (4.9%), spina bifida in 5 (4.9%), anorectal malformation in 4 (3.9%), and trisomy 21 in 1 (1.0%). During follow-up, 8 patients (7.8%) developed CKD stage ≥ 2. Most of these patients had antenatal hydronephrosis, high-grade VUR, dysplastic or non-functioning kidneys, or additional congenital anomalies.
conclusionsIn this cohort, clinically significant CKD developed in a minority of children with PUV, but adverse renal outcome was concentrated in patients with severe upper urinary tract abnormalities and additional congenital anomalies. High-grade VUR, reduced functional renal mass, and complex associated anomalies appear to be important markers of poor renal prognosis. Careful long-term multidisciplinary follow-up remains essential in this patient group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.